# Sotera Health Announces Leadership Transition
Canonical URL: https://biopharmsignal.com/news/SHC/sotera-health-announces-leadership-transition
Ticker: SHC
Company: Sotera Health
Source: Sotera Health
Published: 2026-05-05 11:00 EST
Original Source URL: https://investors.soterahealth.com
## Summary

Alton Shader, CEO of Viant Medical ®, to become CEO and join the Board of Directors, effective May 26, 2026 Chairman and CEO Michael B. Petras, Jr. will serve as Executive Chairman of the Board of Directors CLEVELAND, May 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the

## Article Body
Alton Shader, CEO of Viant Medical ®, to become CEO and join the Board of Directors, effective May 26, 2026 Chairman and CEO Michael B. Petras, Jr. will serve as Executive Chairman of the Board of Directors CLEVELAND, May 05, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the
## Recent Company News
- 2026-05-05 11:04 EST — [Sotera Health Delivers Strong First-Quarter 2026 Results and Reaffirms 2026 Outlook](https://biopharmsignal.com/news/SHC/sotera-health-delivers-strong-first-quarter-2026-results-and-reaffirms-2026-outlook) — Source: Sotera Health
- 2026-05-05 11:00 EST — [Sotera Health Announces Leadership Transition](https://biopharmsignal.com/news/SHC/sotera-health-announces-leadership-transition) — Source: Sotera Health
- 2026-04-21 11:46 EST — [Sotera Health Announces First-Quarter 2026 Earnings Release Date](https://biopharmsignal.com/news/SHC/sotera-health-announces-first-quarter-2026-earnings-release-date) — Source: Sotera Health
- 2026-03-16 11:00 EST — [Sotera Health Appoints Kenneth D. Krause to the Board of Directors](https://biopharmsignal.com/news/SHC/sotera-health-appoints-kenneth-d-krause-to-the-board-of-directors) — Source: Sotera Health
- 2026-03-04 21:51 EST — [Sotera Health Announces Secondary Offering of Common Stock](https://biopharmsignal.com/news/SHC/sotera-health-announces-secondary-offering-of-common-stock) — Source: Sotera Health
## Related News
- 2026-07-21 20:15 EST — BFRG — [BullFrog AI to Participate in Water Tower Research Fireside Chat on Thursday, July 23, 2026](https://biopharmsignal.com/news/BFRG/bullfrog-ai-to-participate-in-water-tower-research-fireside-chat-on-thursday-jul-78357ce8)
- 2026-07-21 20:05 EST — CLPT — [ClearPoint Neuro to Announce Second Quarter 2026 Results August 3, 2026](https://biopharmsignal.com/news/CLPT/clearpoint-neuro-to-announce-second-quarter-2026-results-august-3-2026-6e4f3c05)
- 2026-07-21 20:05 EST — TCMD — [Tactile Medical to Release Second Quarter of Fiscal Year 2026 Financial Results on August 10, 2026](https://biopharmsignal.com/news/TCMD/tactile-medical-to-release-second-quarter-of-fiscal-year-2026-financial-results--798d4004)
- 2026-07-21 20:05 EST — PIII — [P3 Health Partners Schedules Second Quarter 2026 Earnings Release and Conference Call](https://biopharmsignal.com/news/PIII/p3-health-partners-schedules-second-quarter-2026-earnings-release-and-conference-6c9bd8a7)
- 2026-07-21 12:05 EST — VRCA — [Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel](https://biopharmsignal.com/news/VRCA/verrica-pharmaceuticals-and-medomie-pharma-enter-into-exclusive-distribution-mar-abf61522)